Efficacy and Safety of Norketotifen in Uncomplicated Influenza-like Illness
Public ClinicalTrials.gov record NCT04610047. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b Double-blind, Randomized, Placebo-controlled, Parallel-group Study of the Efficacy and Safety of Norketotifen (NKT) in the Treatment of Acute Uncomplicated Influenza-like Illness (ILI)
Study identification
- NCT ID
- NCT04610047
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Emergo Therapeutics, Inc.
- Industry
- Enrollment
- 315 participants
Conditions and interventions
Conditions
Interventions
- Norketotifen Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 64 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 13, 2020
- Primary completion
- Jan 24, 2022
- Completion
- Feb 8, 2022
- Last update posted
- Jan 29, 2023
2020 – 2022
United States locations
- U.S. sites
- 20
- U.S. states
- 14
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Precision Trials AZ | Phoenix | Arizona | 85032 | — |
| Downtown LA Research Center | Los Angeles | California | 90017 | — |
| Omega Research Debary | DeBary | Florida | 32713 | — |
| The Chappel Group Research | Kissimmee | Florida | 34744 | — |
| South Florida Research Center | Miami | Florida | 33135 | — |
| Premier Research Associate | Miami | Florida | 33165 | — |
| Research Institute of South Florida | Miami | Florida | 33173 | — |
| Horizon Research Group of Opelousas | Eunice | Louisiana | 70535 | — |
| Continental Clinical Solutions | Towson | Maryland | 21204 | — |
| Clinical Research of South Nevada | Las Vegas | Nevada | 89121 | — |
| Relief Integrated Health Care | Louisburg | North Carolina | 27549 | — |
| Clinical Research Solutions | Middleburg Heights | Ohio | 44130 | — |
| Frontier Clinical Research | Scottdale | Pennsylvania | 15683 | — |
| Frontier Clinical Research | Smithfield | Pennsylvania | 15478 | — |
| Clinovacare Medical Research Center | West Columbia | South Carolina | 29169 | — |
| Health Concepts | Rapid City | South Dakota | 57702 | — |
| Clinical Research Solutions | Jackson | Tennessee | 38305 | — |
| Cedar Health Research | Dallas | Texas | 75251 | — |
| Advanced Medical Group | Houston | Texas | 77027 | — |
| Frontier Clinical Research | Morgantown | West Virginia | 26505 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04610047, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 29, 2023 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04610047 live on ClinicalTrials.gov.